Careers

Are you interested in being part of the team who will transform cancer care and develop the next generation of targeted therapies for patients?

We are looking for visionaries who love data, have an unwavering commitment to problem-solving and are passionate about making a difference for patients. Are you a thought leader in cancer biology, targeted oncology, machine learning or drug development? Come work with us.

JOIN THE SCORPION TEAM

Scorpion Therapeutics is a precision oncology company founded in February 2020 by a preeminent group of scientists from Harvard University/Massachusetts General Hospital – Keith Flaherty, MD, Gaddy Getz, Ph.D. and Liron Bar-Peled, Ph.D. The company has raised $270M in Series A and Series B financings led by blue-chip investors, including Atlas Venture, Boxer Capital of Tavistock Group, EcoR1 Capital, LLC, Omega Funds, and Vida Venture.

Scorpion’s mission is to serve oncology patients by discovering and developing best-in-class and first-in-class, small molecule cancer medicines that address large patient segments with significant unmet medical needs. To accomplish this mission, we are building a highly collaborative team focused on the pursuit of novel approaches to small molecule drug discovery.  This approach relies upon dynamic collaboration between cancer biology, proteomics, informatics, structural biology and medicinal chemistry – with the ultimate goal of realizing the full potential of targeted/precision oncology.

We are seeking a highly motivated scientist with a demonstrated track record of successes to join our dynamic target biology team in South San Francisco.  This candidate will serve a critical role in generating engineered cell lines and running cell-based experiments to support target validation and mechanistic biology.  This position is ideal for a talented, highly motivated and results-driven individual who will thrive in a fast-paced, innovative, start-up environment.

KEY RESPONSIBILITIES:

  • Executing experiments to inform cancer target biology using a variety of approaches, including CRISPR-mediated cell line engineering, analysis of signaling pathways, and characterization of cell death mechanism(s)
  • Identifying and validating pharmacodynamic readouts for novel oncology targets
  • Using decision making, organizational and communication skills to effectively collaborate with colleagues in data science, chemo-proteomics, and medicinal chemistry
  • Presenting data and findings at various venues, including project team, department, and company meetings

 PROFESSIONAL EXPERIENCE/QUALIFICATIONS

  • B.S./M.S. in Biology or a related field
  • A minimum of 5 years of relevant laboratory experience
  • Experience with lentiviral transduction, stable cell line development, and CRISPR-based gene editing
  • Experience with nucleic acid extraction/purification, qPCR, western blotting, WES, ELISA and other cell and molecular biology techniques
  • Commitment to the highest-quality research with outstanding technical skills and scientific rigor
  • A highly engaged, self-starter who is creative, innovative, communicative and possesses both a collaborative and goal/results-orientated style
  • Desire to work in a fast-paced, multi-tasking environment, while employing tact, patience, diplomacy and a collaborative spirit
  • The desire and ability to contribute to teams working on challenging scientific problems and first-in-class therapeutics
  • A strong record of achievement, including contributing to drug discovery programs and publications is highly desirable
  • Outstanding decision making, organizational and analytical skills
  • Exceptional interpersonal and communication skills

Scorpion Therapeutics Inc., is an Equal Opportunity Employer who strives to create and maintain a diverse working environment. We do not discriminate for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.

APPLY AT CAREERS@SCORPIONTX.COM

Scorpion Therapeutics is a precision oncology company founded in February 2020 by a preeminent group of scientists from Harvard University/Massachusetts General Hospital – Keith Flaherty, MD, Gaddy Getz, Ph.D. and Liron Bar-Peled, Ph.D. – along with entrepreneur and CEO, Gary D. Glick, Ph.D. The company has raised $270M in Series A and Series B financings led by blue-chip investors, including Atlas Venture, Boxer Capital of Tavistock Group, EcoR1 Capital, LLC, Omega Funds, and Vida Venture.

Scorpion’s mission is to serve oncology patients by discovering and developing best-in-class and first-in-class, small molecule cancer medicines that address large patient segments with significant unmet medical needs. To accomplish this mission, we are building a highly collaborative team focused on the pursuit of novel approaches to small molecule drug discovery.  This approach relies upon dynamic collaboration between cancer biology, proteomics, data science, structural biology and medicinal chemistry – with the ultimate goal of realizing the full potential of targeted/precision oncology.

The Data Science team is looking for an exceptional scientist who can develop and integrate cutting-edge cheminformatics solutions and is an enthusiastic cross-functional collaborator. This is a unique opportunity to help build integrated data science solutions in a drug discovery setting. This person will work closely with medicinal chemistry, proteomics, and the data science team to identify opportunities to apply data analytics and machine learning techniques to enhance the Scorpion platform and contribute to our drug discovery pipeline.

KEY RESPONSIBILITIES

  • Work with drug discovery teams to drive data generation, analytics and model development to predict molecular properties
  • Collaborate with the proteomics and Scorpion Library design team to develop machine learning models to predict compound reactivity, cysteine reactivity, identify privileged scaffolds, and contribute to library enhancement campaigns
  • Contribute to the further enhancement of the Data Science platform and infrastructure (generative chemistry, transfer/multi-task learning, multi-objective optimization)
  • Develop custom analytics solutions to enable drug discovery project teams
  • Stay up-to-date with the latest developments in advanced machine learning approaches
  • Pro-actively identify external datasets that could enhance internal datasets for predictive model development

PROFESSIONAL EXPERIENCE/QUALIFICATIONS

  • M.S. or Ph.D. degree in a scientific field coupled with informatics experience, or computational sciences
  • 3+ years of experience supporting and impacting drug discovery teams
  • Expert knowledge of 2D and 3D chemical structure analysis and representation
  • Experience building and validating classification and regression predictive models
  • Comfortable using cheminformatics and data analytics applications such as RDKit, TIBCO Spotfire and KNIME
  • Expertise in a subset of open-source machine learning platforms, such as TensorFlow, Pytorch, Pandas, XGBoost, DeepChem or Scikit-Learn is highly desired
  • Programming and statistical analysis skills, including in Python and R
  • You are a great communicator who enjoys working in a highly integrated, fast-moving cross-functional environment

Scorpion Therapeutics Inc. is an Equal Opportunity Employer who strives to create and maintain a diverse working environment. We do not discriminate for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.

APPLY AT CAREERS@SCORPIONTX.COM

Scorpion Therapeutics is a precision oncology company founded in February 2020 by a preeminent group of scientists from Harvard University/Massachusetts General Hospital – Keith Flaherty, M.D., Gaddy Getz, Ph.D. and Liron Bar-Peled, Ph.D. Scorpion has secured $270 million in financing since it was founded in the first quarter of 2020 with Series A and B rounds led by Atlas Venture, Omega Funds and Vida Venture, with participation by Abingworth, Partners Health Care, and others.

Scorpion’s mission is to serve oncology patients by discovering and developing best-in-class and first-in-class, small molecule cancer medicines that address large patient segments with significant unmet medical needs. To accomplish this mission, we are building a highly collaborative team focused on the pursuit of novel approaches to small molecule drug discovery. This approach relies upon dynamic collaboration between cancer biology, proteomics, informatics, structural biology and medicinal chemistry – with the ultimate goal of realizing the full potential of targeted/precision oncology.

We are looking for a creative, energetic person to join our team as a Laboratory Technician, supporting the set up and day-to-day operations of our research laboratory. The successful candidate will have excellent attention to detail, be able to balance multiple priorities and work independently to support the needs of the scientists. In this position you will be part of an energizing and supportive startup culture engaged in continuous learning, and part of an exceptional team.

KEY RESPONSIBILITIES

  • Contributing and collaborating with a team of scientists and managers by managing day-to-day operations of a first-class laboratory.
  • Compound Management: using the Echo Liquid Dispenser to prepare Assay Ready Plates, shipping to CRO’s when needed, handle receipt of compounds for drug discovery programs, manage onsite compound inventory.
  • Importing Data into Laboratory Information Management System (LIMS)
  • Print and maintain barcode label inventory.
  • Reagent and buffer preparation: prepare and maintain common supply.
  • Cell culture.
  • Inventory: maintain stocks of key reagents/consumables.
  • Contacting vendors to follow up on unreceived orders.
  • Helping to build our laboratory efforts by maintaining and creating a productive, fun and exciting environment.
  • Becoming a valuable contributor to other initiatives as they arise in our fast paced, startup environment.

PROFESSIONAL EXPERIENCE/QUALIFICATIONS

  • B.S. Biology or equivalent
  • Previous laboratory experience.
  • Good communications skills, both oral and written.
  • Experience working independently, but within a collaborative team-centric environment.
  • A highly engaged, self-starter who is creative, innovative, communicative and possesses both a collaborative and goal/results-orientated style.
  • Desire to work in a fast-paced, multi-tasking environment, while employing tact, patience, diplomacy and a collaborative spirit.
  • Outstanding decision making, organizational and analytical skills.

Scorpion Therapeutics Inc. is an Equal Opportunity Employer who strives to create and maintain a diverse working environment. We do not discriminate for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.

APPLY AT CAREERS@SCORPIONTX.COM

Scorpion Therapeutics is a precision oncology company founded in February 2020 by a preeminent group of scientists from Harvard University/Massachusetts General Hospital – Keith Flaherty, MD, Gaddy Getz, Ph.D. and Liron Bar-Peled, Ph.D. – along with entrepreneur Gary D. Glick, Ph.D. The company has raised $270M in Series A and Series B financings led by blue-chip investors, including Atlas Venture, Boxer Capital of Tavistock Group, EcoR1 Capital, LLC, Omega Funds, and Vida Venture.

Scorpion’s mission is to serve oncology patients by discovering and developing best-in-class and first-in-class small molecule cancer medicines that address large patient segments with significant unmet medical needs. To accomplish this mission, we are building a highly collaborative team focused on the pursuit of novel approaches to small molecule drug discovery.  This approach relies upon dynamic collaboration between cancer biology, proteomics, data science, structural biology and medicinal chemistry – with the ultimate goal of realizing the full potential of targeted/precision oncology.

We are seeking a highly motivated, highly experienced medicinal chemist with a demonstrated track record of successes in drug discovery and medicinal chemistry.  This person will provide a leadership role from target selection through hit discovery and optimization of drug candidates by leveraging her/his advanced medicinal chemistry knowledge and managing external resources in support of Scorpion’s projects. This is a unique opportunity to work closely with a skilled group of scientists representing medicinal chemistry, computational chemistry, target and project biology, structural biology and other disciplines to identify new targets and hits and advance programs to the clinic.

KEY RESPONSIBILITIES

  • Co-lead the new target hit identification team to advance new programs to hit-to-lead and beyond.
  • Closely collaborate with the target biology co-lead in the prioritization of new targets, the design and execution of appropriate screening strategies, the validation and triage of screening hits, and the initial SAR exploration around these hits.
  • Collaborate with a team of biologists, data scientists, chemical biologists, biochemists, biophysicists, structural biologists and chemists, both internally and externally to advance our early project portfolio.
  • Lead the covalent library design team aimed at expanding and improving our proprietary covalent compound library.
  • Collaborate with other medicinal chemists and chemistry data scientists in the design of novel compounds that address the project candidate profile
  • Analyze emerging project data and leverage a deep understanding of medicinal chemistry to devise and implement creative scientific strategies to solve project issues
  • Lead and manage a team of external synthetic chemists, applying the best available compound synthesis strategies, to prepare high value compounds
  • Proactively monitor, propose and implement the best medicinal chemistry, hit identification and library design approaches by staying abreast of advances in the field
  • Maintain excellent communication across internal and external team members
  • Define and communicate the screening and medicinal chemistry strategy, critical issues and recommendations to enable appropriate resource decisions
  • Serve as a scientific resource who will champion new technologies/ideas to enhance capabilities.
  • Contribute to the overall advancement of the Scorpion Therapeutics discovery portfolio.

PROFESSIONAL EXPERIENCE/QUALIFICATIONS

  • Ph.D. in chemistry or relevant experience
  • 8+ (and preferably 10+) years of experience contributing to drug discovery programs as a medicinal chemist
  • Experience leading medicinal chemistry teams/programs and delivering candidates for clinical development
  • Experience managing and interacting with synthetic chemistry CROs
  • A strong record of achievement with a broad understanding of synthetic and medicinal chemistry as evidenced by contributions to drug programs and publications in high-impact journals
  • Understanding of other drug discovery disciplines (e.g., biology, biochemistry, safety, PKDM, etc.)
  • Proficient skills in the use of structure-based or other computer-aided design tools
  • Commitment to the highest-quality research with outstanding organizational abilities and scientific execution
  • An enthusiastic self-starter energized by working in a fast-paced, collaborative and results-oriented environment
  • Exceptional interpersonal and communication skills

Scorpion Therapeutics Inc., is an Equal Opportunity Employer who strives to create and maintain a diverse working environment. We do not discriminate for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.

APPLY AT CAREERS@SCORPIONTX.COM

Scorpion Therapeutics is a precision oncology company founded in February 2020 by a preeminent group of scientists from Harvard University/Massachusetts General Hospital – Keith Flaherty, MD, Gaddy Getz, Ph.D. and Liron Bar-Peled, Ph.D. – along with entrepreneur and CEO, Gary D. Glick, Ph.D. The company has raised $270M in Series A and Series B financings led by blue-chip investors, including Atlas Venture, Boxer Capital of Tavistock Group, EcoR1 Capital, LLC, Omega Funds, and Vida Venture.

Scorpion’s mission is to serve oncology patients by discovering and developing best-in-class and first-in-class small molecule cancer medicines that address large patient segments with significant unmet medical needs. To accomplish this mission, we are building a highly collaborative team focused on the pursuit of novel approaches to small molecule drug discovery.  This approach relies upon dynamic collaboration between cancer biology, proteomics, data science, structural biology and medicinal chemistry – with the ultimate goal of realizing the full potential of targeted/precision oncology.

We are seeking a highly motivated, experienced medicinal chemist with a demonstrated track record of successes in drug discovery and synthetic organic chemistry.  This person will provide leadership in the discovery of drug candidates though advanced medicinal chemistry and help manage external resources in support of Scorpion’s projects from hit ID to development candidate identification. This is a unique opportunity to work closely with a skilled group of scientists representing medicinal chemistry, computational chemistry, biology, structural biology and other disciplines to advance programs to the clinic.

KEY RESPONSIBILITIES

  • Closely collaborate with other medical chemists and computational chemists in the design of novel compounds that address the project candidate profile
  • Analyze emerging project data and leverage a deep understanding of synthetic and medicinal chemistry to devise and implement creative scientific strategies to solve project issues
  • Lead and manage a team of external synthetic chemists, applying the best available compound synthesis strategies, to prepare high value compound targets
  • Collaborate with project teams to identify discover quality development candidates in an efficient and rapid manner by helping define issues, screening strategies, experiments and influence team direction
  • Proactively monitor, propose and implement the best medicinal chemistry approaches for Scorpion programs by staying abreast of advances in the field
  • Maintain excellent communication across internal and external team members
  • Proactively communicate strategy, critical issues and recommendations to enable appropriate resource decisions
  • Serve as a scientific resource to the company who will champion new technologies/ideas to enhance capabilities.

PROFESSIONAL EXPERIENCE/QUALIFICATIONS

  • Ph.D. in chemistry, specializing in synthetic organic synthesis or relevant experience
  • 3+ (and preferably 5+) years of experience supporting the synthetic and medicinal chemistry of drug discovery project teams
  • Experience managing and interacting with synthetic chemistry CRO’s
  • A strong record of achievement with a broad understanding of synthetic and medicinal chemistry as evidenced by contributions to drug programs and publications in high-impact journals
  • Understanding of other drug discovery disciplines (e.g., biology, safety, PKDM, etc.)
  • Proficient skills in the use of structure-based or other computer-aided design tools
  • Experience participating on a team that has advanced compounds to clinical development is preferred
  • Commitment to the highest-quality research with outstanding organizational abilities and scientific execution
  • An enthusiastic self-starter energized by working in a fast-paced, collaborative and results-oriented environment
  • Exceptional interpersonal and communication skills

Scorpion Therapeutics Inc., is an Equal Opportunity Employer who strives to create and maintain a diverse working environment. We do not discriminate for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.

APPLY AT CAREERS@SCORPIONTX.COM

Scorpion Therapeutics is a precision oncology company founded in February 2020 by a preeminent group of scientists from Harvard University/Massachusetts General Hospital – Keith Flaherty, MD, Gaddy Getz, Ph.D. and Liron Bar-Peled, Ph.D. The company has raised $270M in Series A and Series B financings led by blue-chip investors, including Atlas Venture, Boxer Capital of Tavistock Group, EcoR1 Capital, LLC, Omega Funds, and Vida Venture.

Scorpion’s mission is to serve oncology patients by discovering and developing best-in-class and first-in-class, small molecule cancer medicines that address large patient segments with significant unmet medical needs. To accomplish this mission, we are building a highly collaborative team focused on the pursuit of novel approaches to small molecule drug discovery.  This approach relies upon dynamic collaboration between cancer biology, proteomics, data science, structural biology and medicinal chemistry – with the ultimate goal of realizing the full potential of targeted/precision oncology.

All projects at Scorpion are run by project teams and project team leaders are directly accountable for the success of our drug-discovery programs and the value creation they enable.   Project Team Leaders are given significant autonomy and resources to prosecute projects rapidly, efficiently, and at the highest scientific and industry standards. Given their importance to our company and this operating model, project team leaders are directly accountable to and report to senior management.

We are seeking a highly motivated, experienced research Project Leader with a demonstrated track record of success in leading oncology small molecule projects from discovery into early clinical testing. He/she will be accountable for setting project strategy and leading project execution with the goal of advancing clinical candidates with compelling data packages in line with our overall corporate goals.

The successful candidate, along with a chemistry colleague, will lead a multi-disciplinary project team to drive oncology small molecule drug discovery from inception into the clinic. He/she will define the path to drug discovery from target validation to candidate selection through leveraging internal and external resources. The candidate must have demonstrated experience in all aspects of identifying, characterizing and advancing high-quality drug candidates into first-in-man clinical trials, including defining biomarker strategy, patient stratification, and proof-of-mechanism endpoints. The candidate will be expected to develop strong, collaborative partnerships within the company, with academic investigators associated with the company, and with CROs.

KEY RESPONSIBILITIES

  • Directly lead small-molecule drug discovery programs.
  • Design and implement project strategies leading to the identification of high-quality development drug candidates.
  • Identify key decision points and manage risk and expectations to meet short and long-term objectives successfully.
  • Coordinate research activities and effectively allocate resources between internal staff and external CROs.
  • Proactively communicate project strategy, critical issues and recommendations to enable appropriate resource decisions.
  • Maintain excellent communication across internal and external team members.

 

PROFESSIONAL EXPERIENCE/QUALIFICATIONS

  • Ph.D. degree in biochemistry, (cancer) biology, pharmacology, or related discipline.
  • 10 years of hands-on small molecule drug discovery experience in the oncology therapeutic area in an industrial setting.
  • Demonstrable hands-on experience in all aspects of advancing small molecule drugs through lead optimization to candidate selection, with broad knowledge across multiple disciplines including pharmacology, pharmacokinetics, medicinal chemistry, ADME and toxicology.
  • Demonstrated leadership of multidisciplinary project teams through all stages of small molecule discovery including candidate selection with the ability to define strategy and provide leadership.
  • Deep understanding of small molecule drug discovery – instinctive identification of critical success factors, anticipation of issues before they occur and mitigation of risk while driving a program forward.
  • A deep and broad understanding of cancer biology, including preclinical and translational aspects.
  • Demonstrated ability to lead, organize and manage productive, cross-functional and cross-site teams.
  • Exceptional scientific rigor coupled with experience in high-level decision making.
  • The desire and ability help lead teams working on challenging scientific problems and first-in-class therapeutics.
  • Commitment to the highest-quality research with outstanding organizational abilities and scientific execution.
  • A highly engaged, self-starter who is creative, innovative, communicative and possesses both a collaborative and goal/results-orientated style.
  • Desire to work in a fast-paced, multi-tasking environment, while employing tact, patience, diplomacy, and a collaborative spirit.
  • Outstanding oral and written communication skills.

Scorpion Therapeutics Inc., is an Equal Opportunity Employer who strives to create and maintain a diverse working environment. We do not discriminate for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.

APPLY AT CAREERS@SCORPIONTX.COM

Scorpion Therapeutics is a precision oncology company founded in February 2020 by a preeminent group of scientists from Harvard University/Massachusetts General Hospital – Keith Flaherty, MD, Gaddy Getz, Ph.D. and Liron Bar-Peled, Ph.D. The company has raised $270M in Series A and Series B financings led by blue-chip investors, including Atlas Venture, Boxer Capital of Tavistock Group, EcoR1 Capital, LLC, Omega Funds, and Vida Venture.

Scorpion’s mission is to serve oncology patients by discovering and developing best-in-class and first-in-class, small molecule cancer medicines that address large patient segments with significant unmet medical needs. To accomplish this mission, we are building a highly collaborative team focused on the pursuit of novel approaches to small molecule drug discovery.  This approach relies upon dynamic collaboration between cancer biology, proteomics, data science, structural biology and medicinal chemistry – with the ultimate goal of realizing the full potential of targeted/precision oncology.

We are seeking a highly motivated, experienced in vivo pharmacologist with experience developing and utilizing mouse tumor models to support oncology drug discovery in an industry setting. He/she will be accountable for planning and executing in vivo pharmacology studies to support the optimization and identification of development candidates with compelling data packages to support first-in-human clinical studies.

The successful candidate will lead in vivo pharmacology activities to drive oncology small molecule drug discovery from in vivo target validation, through lead optimization to translational studies supporting early clinical development. He/she will use internal and external resources to identify and develop appropriate in vivo tumors models that represent target dependence, tumor genetics and indication and leverage these models through each stage of drug discovery. The candidate must have demonstrated this experience in an industry working with multidisciplinary projects team in advancing high-quality drug candidates into first-in-man clinical trials.  The candidate will be expected to develop strong, collaborative partnerships within the company, with academic investigators associated with the company, and with CROs.

KEY RESPONSIBILITIES

  • Design and lead the execution of PK/PD/efficacy studies using small molecule drug candidates in mouse tumor models.
  • Contribute to decision-making on small molecule drug discovery teams.
  • Work closely with Early Target Biology team to perform in vivo validation studies using genetic tools for novel oncology targets.
  • Establish best practices for developing, characterizing and documenting methods (e.g. IACUC protocols) for a range of rodent tumor models in-house.
  • Anticipate project-by-project needs for tumor models, pharmacodynamic, efficacy endpoints and establish capabilities pro-actively.
  • Develop in vitro methods for analyzing pharmacodynamic endpoints in tumor and normal tissues from rodent studies (qPCR, Western blot, HTRF, etc).
  • Work with contract research organizations and academic collaborators to access novel tumor models and patient-derived xenografts.
  • Maintain excellent communication across internal and external team members to ensure project challenges and issues are understood and needs are met. 

PROFESSIONAL EXPERIENCE/QUALIFICATIONS

  • Ph.D. degree in pharmacology, biology, or related discipline.
  • 5-10 years of hands-on experience supporting small molecule drugs through lead optimization to candidate selection, with broad knowledge across multiple disciplines including cancer biology and pharmacology.
  • Experience working collaboratively with IACUC and vivarium staff to ensure studies are executed with the highest standards, following self-written protocols.
  • Demonstrated leadership within in vivo pharmacology working on a multidisciplinary project teams through all stages of small molecule discovery.
  • Hands-on experience in rodent handling, husbandry, dosing, tumor model development, surgery, dissection with demonstrated ability to teach and mentor.
  • A deep and broad understanding of cancer biology, including preclinical and translational aspects.
  • Exceptional scientific rigor coupled with experience in high-level decision making.
  • Commitment to the highest-quality research with outstanding organizational abilities and scientific execution.
  • A highly engaged, self-starter who is creative, innovative, communicative and possesses both a collaborative and goal/results-orientated style.
  • Desire to work in a fast-paced, multi-tasking environment, while employing tact, patience, diplomacy and a collaborative spirit.
  • Outstanding oral and written communication skills.

Scorpion Therapeutics Inc., is an Equal Opportunity Employer who strives to create and maintain a diverse working environment. We do not discriminate for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.

APPLY AT CAREERS@SCORPIONTX.COM

Scorpion Therapeutics is a precision oncology company founded in February 2020 by a preeminent group of scientists from Harvard University/Massachusetts General Hospital – Keith Flaherty, MD, Gaddy Getz, Ph.D.and Liron Bar-Peled, Ph.D. – along with entrepreneur and CEO, Gary D. Glick, Ph.D. The company has raised $270M in Series A and Series B financings led by blue-chip investors, including Atlas Venture, Boxer Capital of Tavistock Group, EcoR1 Capital, LLC, Omega Funds, and Vida Venture.

Scorpion’s mission is to serve oncology patients by discovering and developing best-in-class and first-in-class, small molecule cancer medicines that address large patient segments with significant unmet medical needs. To accomplish this mission, we are building a highly collaborative team focused on the pursuit of novel approaches to small molecule drug discovery. This approach relies upon dynamic collaboration between cancer biology, proteomics, informatics, structural biology and medicinal chemistry – with the ultimate goal of realizing the full potential of targeted/precision oncology.

This is a unique opportunity to join an early-stage biotechnology company that combines world-class genomics, chemical proteomics and data science capabilities and contributes to bringing drugs towards the clinic. We are a highly integrated drug discovery company and are looking for a results-oriented team player who enthusiastically integrates computational chemistry, computational biophysics, structural informatics and cheminformatics approaches to help drive Scorpion Therapeutics’ drug discovery programs.

KEY RESPONSIBILITIES

  • Provide integrated computational chemistry support to enable efficient lead discovery and optimization
  • Utilize ligand- and receptor-based screening approaches to identify starting points for novel targets
  • Integrate novel computational biophysics approaches like molecular dynamics and free energy perturbation
  • Contribute to the development of computational infrastructure by identification of novel tools and techniques
  • Collaborate within the Data Science team to help integrate data analytics approaches into all aspects of drug discovery

QUALIFICATIONS

  • Passionate drug hunter
  • Ph.D. with 6+ years of computational chemistry support in a pharmaceutical and/or biotechnology environment
  • Demonstrated contributions to drug discovery programs through the application of computational chemistry techniques
  • Proficiency with a broad range of modern computational chemistry techniques
  • Experience with full Schrödinger software suite a plus

Scorpion Therapeutics is a precision oncology company founded in February 2020 by a preeminent group of scientists from Harvard University/Massachusetts General Hospital – Keith Flaherty, MD, Gaddy Getz, Ph.D. and Liron Bar-Peled, Ph.D. The company has raised $270M in Series A and Series B financings led by blue-chip investors, including Atlas Venture, Boxer Capital of Tavistock Group, EcoR1 Capital, LLC, Omega Funds, and Vida Venture.

Scorpion’s mission is to serve oncology patients by discovering and developing best-in-class and first-in-class, small molecule cancer medicines that address large patient segments with significant unmet medical needs. To accomplish this mission, we are building a highly collaborative team focused on the pursuit of novel approaches to small molecule drug discovery.  This approach relies upon dynamic collaboration between cancer biology, proteomics, informatics, structural biology and medicinal chemistry – with the ultimate goal of realizing the full potential of targeted/precision oncology.

We are seeking a highly motivated scientist with a demonstrated track record of successes to join our dynamic target biology team in South San Francisco.  This candidate will serve a critical role in generating engineered cell lines and running cell-based experiments to support target validation and mechanistic biology.  This position is ideal for a talented, highly motivated and results driven individual who will thrive in a fast-paced, innovative, start-up environment.

KEY RESPONSIBILITIES

  • Designing and executing experiments to inform cancer target biology using a variety of approaches, including CRISPR-mediated cell line engineering, analysis of signaling pathway, and characterization of cell death mechanism(s)
  • Utilizing knockdown, knockout and over-expression of proteins for target validation
  • Identifying and validating pharmacodynamic readouts for novel oncology targets
  • Using decision making, organizational and communication skills to effectively collaborate with colleagues in data science, chemo-proteomics, and medicinal chemistry
  • Presenting data and findings at various venues, including project team, department, and company meetings

 PROFESSIONAL EXPERIENCE/QUALIFICATIONS

  • BS in Biology or a related field
  • 3-5 years of relevant laboratory experience
  • Proficient at lentiviral transduction, stable cell line development, and CRISPR-based gene editing
  • Proficient at nucleic acid extraction/purification, qPCR, western blotting, WES, ELISA and other cell and molecular biology techniques
  • Commitment to the highest-quality research with outstanding technical skills and scientific rigor
  • A highly engaged, self-starter who is creative, innovative, communicative and possesses both a collaborative and goal/results-orientated style
  • Desire to work in a fast-paced, multi-tasking environment, while employing tact, patience, diplomacy and a collaborative spirit
  • The desire and ability to contribute to teams working on challenging scientific problems and first-in-class therapeutics
  • A strong record of achievement, including contributing to drug discovery programs and publications is highly desirable
  • Outstanding decision making, organizational and analytical skills
  • Exceptional interpersonal and communication skills

Scorpion Therapeutics Inc., is an Equal Opportunity Employer who strives to create and maintain a diverse working environment. We do not discriminate for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.

APPLY AT CAREERS@SCORPIONTX.COM